5/3/2011
Rutgers Offers Hope in New Treatment for Spinal Cord Injuries
3/18/2011
In a Phase 2 Study PF-04523655 (RTP801I-14) Showed Improved Vision Over Standard of Care in Patients with Diabetic Macular Edema at 12 Months

  
2012
2011
2010
2009
2008
2007
2006
2005
Web Development HomeProductsContact ©2007 Quark Pharmaceuticals, Inc.